• NEXT-ChemX completed a debt-for-equity swap, issuing 80,000 newly authorized Series B Preferred Shares to two accredited investors.
• The transaction cut balance-sheet debt by $400,000, reflecting $200,000 of secured debt canceled for each investor.
• Holders also extended most Series B Preferred Convertible Promissory Notes, including defaulted notes, to Dec. 31, 2026.
• The Series B issuance gave the two investors about 58% voting control, based on 40,000,000 votes versus 28,546,835 common shares outstanding.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NEXT-ChemX Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-034145), on July 22, 2026, and is solely responsible for the information contained therein.